In addition to the effects of TXS inhibition on tumour cell survival mechanisms, examination of downstream genetic pathways implicated in tumourigenesis is also of particular interest in NSCLC, with the potential to provide further insight into the anti-tumour effects of TXS inhibition. This evidence concerns the gene TBXAS1 and non-small cell lung carcinoma.